How to improve postgenomic knowledge discovery using imputation by Sehgal, Muhammad Shoaib B et al.
 
This is the published version of: 
 
Sehgal, M. S. B., et al. (2011). How to improve postgenomic knowledge 
discovery using imputation. EURASIP Journal on Bioinformatics and 
Systems Biology. 1, p. 1-14 
 
Available online at http://doi.org/10.1155/2009/717136  
 
 
Copyright © Muhammad Shoaib B. Sehgal et al. 2009. This is an open-
access article distributed under the terms of the 
Creative Commons Attribution License 
(http://creativecommons.org/licenses/by/2.0/), which permits 
unrestricted use, distribution, and reproduction in any medium, provided 
the original work, first published in the EURASIP Journal on 
Bioinformatics and Systems Biology, is properly cited. The complete 
bibliographic information, a link to the original publication on https://bsb-
eurasipjournals.springeropen.com, as well as this 
copyright and license information must be included. 
COPYRIGHT NOTICE             
 
 
 
FedUni ResearchOnline 
http://researchonline.federation.edu.au 
 
  
Hindawi Publishing Corporation
EURASIP Journal on Bioinformatics and Systems Biology
Volume 2009, Article ID 717136, 14 pages
doi:10.1155/2009/717136
Research Article
How to Improve Postgenomic Knowledge Discovery
Using Imputation
Muhammad Shoaib B. Sehgal,1, 2 Iqbal Gondal,3 Laurence S. Dooley,4 and Ross Coppel2, 5
1ARC Centre of Excellence in Bioinformatics, Institute for Molecular Bioscience (IMB), University of Queensland,
St Lucia, QLD 4067, Australia
2Victorian Bioinformatics Consortium, Monash University, VIC 3800, Australia
3Gippsland School of Information Technology (GSIT), Faculty of Information Technology, Monash University,
Churchill, VIC 3842, Australia
4 Faculty of Mathematics, Computing and Technology, The Open University, Milton Keynes MK7 6BJ, UK
5Department of Microbiology, Monash University, VIC 3800, Australia
Correspondence should be addressed to Iqbal Gondal, iqbal.gondal@infotech.monash.edu.au
Received 28 February 2008; Revised 8 September 2008; Accepted 4 November 2008
Recommended by Erchin Serpedin
While microarrays make it feasible to rapidly investigate many complex biological problems, their multistep fabrication has the
proclivity for error at every stage. The standard tactic has been to either ignore or regard erroneous gene readings as missing values,
though this assumption can exert a major influence upon postgenomic knowledge discovery methods like gene selection and gene
regulatory network (GRN) reconstruction. This has been the catalyst for a raft of new flexible imputation algorithms including local
least square impute and the recent heuristic collateral missing value imputation, which exploit the biological transactional behaviour
of functionally correlated genes to aﬀord accurate missing value estimation. This paper examines the influence of missing
value imputation techniques upon postgenomic knowledge inference methods with results for various algorithms consistently
corroborating that instead of ignoring missing values, recycling microarray data by flexible and robust imputation can provide
substantial performance benefits for subsequent downstream procedures.
Copyright © 2009 Muhammad Shoaib B. Sehgal et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1. Introduction
The study of genes and their transactional relationship with
other genes can be modelled using machine learning algo-
rithms in a diverse range of applications from disease analysis
[1] and drug progression for target diseases [2] through
evolutionary study [3] and comparative genomics [4], all of
which are characterised by using microarray gene expression
data. The statistical analysis of microarray datasets depends
highly upon the accuracy of the gene expression methods.
Microarray production is a complex process, whereby sam-
ples are prepared for diﬀerential expression in a series of
stages involving the laying of specimens on the slides by a
robotic arm, imaging of the slides, and finally determining
the numerical gene expression values. Each step inevitably
exhibits a propensity for error [5], a corollary to this is the
inherent erroneous gene expression values for certain genes,
which are popularly referred to as missing values. While
microarray technology is continually being refined, there
is an enormous amount of public domain gene expression
data available that frequently contains at least 5% erroneous
spots. Indeed, in many datasets, at least 60% of genes have
either one or more missing values [6], which can seriously
impact on subsequent data analysis involving, for example,
significant gene selection, gene regulatory network (GRN)
reconstruction, and clustering algorithms [7, 8].
The simplest ways to address this problem are to either
repeat the experiment, though this is often not feasible
for economic reasons, or ignore those samples containing
missing values, but again this is not recommended because of
the limited number of available samples. Alternative strate-
gies include row average/median imputation (substitution
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by the corresponding row average/median value) and the
ubiquitous ZeroImpute, where missing values are replaced
by zero. Both approaches are high variance, with neither
exploiting the underlying data correlations which can lead
to higher estimation errors [9]. The prevailing wisdom
is to accurately estimate missing values by exploiting the
latent correlation structure of the microarray data [8, 10],
as manifested by the development of numerous microarray
imputation techniques including collateral missing value
estimation (CMVE) [11], singular value decomposition impute
(SVDImpute) [9], K-nearest neighbour (KNN) [9], least
square impute (LSImpute) [10], local LSimpute (LLSImpute)
[8], Bayesian principal component analysis (BPCA) [12], a set
of theoretic framework based on projection onto convex sets
imputation (POCS Impute) method [13] and most recently,
heuristic collateral missing value imputation (HCMVI) [14].
In addition, other methods which use contextual informa-
tion include gene ontology-based imputation (GOImpute)
[15] and metadata-based imputation technique [16].
This paper will investigate the gene expression correla-
tion assumption by empirically analysing diﬀerent postge-
nomic knowledge discovery methods including gene selec-
tion and GRN reconstruction techniques in the presence
of missing values, specifically for the breast and ovarian
cancer datasets of Hedenfalk et al. [17] and Jazaeri et al.
[18], respectively. The rationale for choosing these two
datasets is that generally cancerous data [19] lacks molecular
homogeneity in tumour tissues, which makes missing value
estimation far more challenging. Additionally, breast cancer
is the second leading cause of cancer death in women today
(following lung cancer), with 1 in 11 Australian women
being diagnosed with the disease before the age of 75, and
the number of breast cancer patients increasing everyday,
as diagnosis methods improve [20]. Ovarian cancer is the
fourth most common cause of cancer-related deaths in
American women of all ages, as well as being the most
prevalent cause of death from gynaecologic malignancies in
the United States [21].
Figure 1 displays a generic postgenomic knowledge
inference framework, with the DNA sample being firstly
converted to expression values prior to any knowledge
inference being undertaken. As highlighted earlier, this
phase (STEP 1 in Figure 1) can introduce several erroneous
(missing) values that can significantly impact upon any sub-
sequent analysis. Unfortunately, while there have been many
propitious imputation algorithmic contributions (STEP 2),
there is still the pervading fallacy that either new data
analysis methods will successfully manage missing values or
more seriously that missing values in fact do not impact
appreciably upon downstream analysis [22]. Interestingly,
even though there have been some attempts to test the
impact of imputation on clustering methods [23, 24], no
comprehensive single study has been undertaken to date
to analyse the impact missing values can have on diﬀerent
postgenomic knowledge discovery methods like gene selec-
tion, class prediction, clustering of functionally related genes,
and GRN reconstruction (STEP 4). This paper cogently
argues that imputation is both an integral and indeed
mandatory preprocessing step (STEP 2) prior to applying
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Figure 1: A Schematic representation of postgenomic knowledge
discovery framework.
any knowledge discovery method (STEP 4). This judgement
is justified by analysing various results which consistently
reveal improved estimation accuracy when missing values are
approximated by more flexible approaches such as HCMVI
and LLSImpute (STEP 3) because of their innate ability to
preserve the variance of the data compared to other popular,
if simpler, high-variance methods.
Aside from the obvious numerical relevance of missing
value estimation, another key driver is the biological signif-
icance of imputation, particularly algorithmic performance
in estimating significant genes in microarray data that may
be erroneously aﬀected. Plakophilin 2 (PKP2), for example,
is present in breast carcinoma cell lines [25] and is significant
as it serves as a marker for the identification and character-
isation of carcinomas derived either from or corresponding
to, simple, and complex epithelia [26]. As will be witnessed
in Section 6, PKP2 is often not selected by gene selection
methods when missing values are present and so would
generally be either ignored or replaced when conventional
estimation methods are applied. By judiciously employing a
flexible imputation strategy such as HCMVI, however, the
probability that these genes are correctly selected can be
significantly enhanced. Similarly, the GRN reconstruction
performance may be significantly influenced by missing
values with a substantial number of vital coregulation
links being neglected when imputing by traditional and
contemporary methods (Sections 3 and 4). The interaction
in breast cancer data between ADP-ribosylation factor 3
and estrogen sulfotransferase (EST) , which is similar to
the NSAP1 protein, is, for instance, consistently overlooked
when missing values are introduced, though they have been
successfully reconstructed using flexible imputation methods
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(Section 5). In both scenarios, accurate imputation crucially
eliminates the need for repeating an experiment which can
be costly, and may be pragmatically infeasible.
This paper presents a treatise on existing imputation
methods by examining their performance in managing
microarray dataset missing values to improve postge-
nomic knowledge discovery. Concomitant with analysing the
numerical accuracy of imputation, the biological significance
for two proteins is analysed, namely, KIAA1025 and MHC,
from the breast and ovarian cancer datasets, respectively,
because of their acknowledged importance in diagnosing the
diﬀerent cancer types [27–29].
The remainder of the paper is organised as follows. After
formally defining the nomenclature, Sections 3, 4, and 5 will,
respectively, review the gamut of traditional, contemporary,
and flexible microarray missing value imputation algorithms
together with their particular epithets and limitations. A
reflective analysis is then presented in Section 6 upon a series
of experiments performed on various breast and ovarian
cancer microarray datasets, including both statistical and
biological significance interpretations, while some conclu-
sions are provided in Section 7.
2. Nomenclature
The convention adopted in all the imputation strategies is
to assume that the gene expression matrix Y has m rows
and n columns, where the rows and columns represent genes
and samples, respectively, as in (1). A missing value in
gene expression data Y for gene i and sample j is formally
expressed as Yi j
Y =
⎡
⎢⎢⎢⎢⎢⎣
g11 g12 g13 · · · g1n
g21 g22 g23 · · · g2n
· · · · · · ·
· · · · · · ·
gm1 gm2 gm3 · · · gmn
⎤
⎥⎥⎥⎥⎥⎦
∈ Rm×n. (1)
Imputation strategies have been broadly classified into
three categories: traditional, contemporary, and flexible
techniques. Original imputation approaches, which replace
a missing value by either zero or row/column mean, are des-
ignated as traditional, as they are simple and computationally
eﬃcient, but do not take advantage of any latent correlation
within the data. Contemporary techniques subsequently
evolved to improve the estimation accuracy by using inherent
data correlations, usually under the assumption that the
causal correlation structure is either localised or globalised.
They are also characterised by using a fixed number of
predictor genes in the estimation which limits the flexibility
to fully exploit any data correlations. This was the incentive
for the most recent family of flexible imputation methods
which are able to freely adapt to the data distribution by
automatically determining the optimal number of predictor
genes, thereby minimising the impact of missing values on
subsequent biological analysis. In the following sections,
these three imputation categories are, respectively, reviewed.
3. Traditional Imputation Techniques for
Microarray Data
These are broadly characterised by replacing expression
values of those genes that posses missing values by zero,
their gene/sample mean or median, and in certain cases,
by using the well-known KNN method. The advantages
and disadvantages of these popular approaches are now
discussed.
3.1. ZeroImpute and Mean/Median Imputation. In these
methods, missing values are, respectively, replaced either by
zero (ZeroImpute) or by the gene/sample average [30] and/or
median. The attraction is their simplicity and computational
eﬃciency, though none take advantage of the underlying
correlation structure of the data, with the consequence that
the data variance is generally high. This means that when
there are a large number of missing values present in the
microarray data, these imputation strategies can significantly
compromise subsequent postgenomic analysis. The impact,
however, can be reduced by adapting the estimation param-
eters to the underlying correlation structure of the data,
with the following sections examining some well-established
methods.
3.2. Singular Value Decomposition-Based Imputation (SVD-
Impute). This uses the combination of singular value decom-
position (SVD) [9] and expectation maximization (EM)
[31] to estimate the missing values by calculating mutually
orthogonal expression patterns often referred to as Eigen
genes. As SVD calculations require the entire matrix, missing
values are replaced by their row mean prior to the k
most eﬀective Eigen genes being selected according to their
corresponding Eigen values. The imputed missing value
estimate for Yi j is then calculated by regressing gi against
the k most eﬀective Eigen genes with expression values from
sample j which contained the missing value being ignored.
SVDImpute reduces imputation errors by recursively esti-
mating the missing values using the EM algorithm until the
change in the matrices becomes less than an empirically
determined threshold, nominally 0.01 [9]. The technique
performs best when 20% of the Eigen genes are used for
estimation, and while it is a better strategy than high-
variance approaches like ZeroImpute, it has the drawbacks
of both being highly sensitive to noise and only considering
global data correlations, which inevitably leads to higher
estimation errors in locally correlated datasets.
3.3. K-Nearest Neighbour (KNN) Estimation. KNN [9] esti-
mates missing values by searching for the k nearest genes
normally by applying the Euclidean distance and then taking
the weighted average of these k genes. The k genes whose
expression vectors are most similar to genetic expression
values in all samples,except the sample which contains the
missing value, are selected. The similarity measure between
gene gi and other genes is then determined by the Euclidian
distance over the observed components in sample j, and
the missing value estimated as the weighted average of the
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corresponding entries in the selected k expression vectors,
where the contribution of every gene is scaled by the
similarity of its expression to gi.
While KNN is flexible in terms of the choice of similarity
measure, it does imply the performance of a specific metric
is data dependent. Troyanskaya et al. [9] demonstrated that
Euclidean distance performs better than other similarity
measures for microarray data, and though it is highly
sensitive to microarray data outliers, log-transforming the
data can significantly reduce their eﬀect in determining gene
similarity.
The choice of an appropriate k value especially influ-
ences imputation performance. Experimental results have
established that for small datasets k = 10 is the best choice
[7], while Troyanskaya et al. [9] observed that KNN is
insensitive to values of k in the range 10 to 20. The key point
to emphasise is that regardless of the underlying structure
of the microarray data, a preset value of k is employed
which clearly does not fully harness the capability of an
imputation method. A much more creative strategy is to
endeavour to automatically determine the best k value from
the data correlation structure, which is the fundamental
premise of the two flexible imputation techniques described
in Section 5.
Summarising, while traditional algorithms have been
widely adopted, the inherently high data variance has a major
impact on downstream analysis methods like significant
gene selection and class prediction GRN reconstruction. To
relax this restriction, more robust techniques have evolved
in an attempt to garner superior performance in terms of
estimation accuracy, although as will be witnessed, they still
exhibit some limitations, most notably from a biological
significance perspective. Section 4 focuses on some of the
most well-established contemporary imputation approaches.
4. Contemporary Imputation Techniques for
Microarray Data
This category embraces those methods that implicitly
attempt to lower the data variance of missing value estimates,
by seeking to exploit the underlying localised or global
correlation structure of the microarray data. Some of the
most popular algorithms together with their relative merits
and demerits will now be investigated.
4.1. Least Square Impute (LSImpute) Estimation. This is
a regression-based method that exploits the correlation
between genes. There are three variants of the impu-
tation LSImpute [10] algorithm, namely, LSImpute-Gene,
LSImpute-Array, and LSImpute-Adaptive. LSImpute-Gene
estimates missing values using the correlation between the
genes (intrasample) while LSImpute-Array exploits inter-
sample correlation while LSImpute-Adaptive combines both
techniques using a bootstrapping approach [32]. The com-
munal features of all three LSImpute variants will now be
delineated.
To estimate missing value Yi j in (1), the k most-
correlated genes are firstly selected, whose expression vectors
are similar to gene i from Y in all samples except j, where
all the correlated genes do not contain any missing values.
As LSImpute-Gene is based upon a regression, it mandates
that the number of model parameters must be lower than the
number of observations, though in general for microarray
data, the number of genes is usually much greater than the
sample number. The algorithm then computes regressive
estimates for each selected gene and the missing value
estimate is obtained from their weighted average.
While LSImpute-Gene aﬀords greater accuracy than
traditional imputation methods like KNN and SVDImpute
(Section 3), it still has the same fundamental limitation
of using a preset k value. Bø et al. [10], for example,
empirically determined k = 10 as the most suitable value
for their particular dataset, though crucially this finding is
data dependent and not generic. It also demonstrated that
this imputation approach works better if missing values
have been initially approximated by LSImpute-Gene and then
refined with LSImpute-Array. This lowers the imputation
error, though commensurately it increases the computational
overhead, and since it still employs LSImpute-Gene prior to
any estimation, the value of k is always fixed.
LSImpute-Adaptive combines the strengths of both
LSImpute-Gene and LSImpute-Array by fusing their respec-
tive imputation results. It modifies the weights for each
imputation using a bootstrapping process [32], with empir-
ical results [10] endorsing that this strategy performs better
when either variant is separately applied.
With the flexibility to adjust the number of predictor
genes in the regression, LSImpute performs best when
data exhibits a strong local correlation structure, though
the comparative prediction accuracy is still inferior to
that achieved by the new flexible imputation algorithms,
which dynamically determine k directly from the data
(Section 5).
4.2. Bayesian Principal Component Analysis (BPCA) Estima-
tion [12]. BPCA estimates missing values using Bayesian
estimation theory with a variational algorithm [33] to
calculate the model parameters and ultimately the imputed
value Yi j . The posteriori distribution p(Yij) of the missing
value and the posteriori distribution p(θ) of the model
parameter θare firstly computed from gene values having
no missing values and since this distribution calculation
requires the complete matrix, so missing values are replaced
by their corresponding gene averages. The model parameters
p(θ) are then used to compute the current posteriori distri-
bution, with the maximum likelihood [32] parameters being
iteratively updated using the current posteriori distribution
of model parameters and missing values, until convergence
is reached.
By considering only global correlations within a dataset,
BPCA has a distinct advantage in terms of prediction speed
compared with all the other imputation techniques analysed,
but its performance is highly dependent on either a strong
underlying global correlation within the data or having a very
high number of samples. This is an oﬀset by the likelihood
of high imputation errors when either the dataset is locally
correlated or comprises a small number of samples.
EURASIP Journal on Bioinformatics and Systems Biology 5
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Figure 2: Gene selection accuracy for 50 significant genes in breast
cancer.
4.3. Collateral Missing Value Estimation (CMVE) [11]. This
algorithm is unique in contemporary missing value imputa-
tion techniques in using multiple estimates. Like LSImpute,
it firstly estimates the missing value Yi j by identifying the k
most-correlated genes, with either a covariance or Pearson
correlation matrix being employed, depending upon the data
distribution to find these correlated genes. LS regression and
two variants of the nonnegative LS (NNLS) algorithm are
then applied to compute three separate estimates for Yi j ,
which are then linearly fused as follows:
Yij = ρ·Φ1 + Δ·Φ2 + Λ·Φ3, (2)
where ρ, Δ, and Λ are the weights assigned to each
constituent imputation estimate.
CMVE uses LS regression of k-correlated genes for the
first missing value estimate Φ1, while NNLS and linear
programming compute the other two estimates Φ2 and Φ3.
The rationale for including NNLS is that unnormalised
microarray data has only positive values so NNLS takes
advantage of exploiting the positive search space. If the
data is either normalized or log-transformed then it will
contain some negative values so LS regression is used for this
particular estimation. Since both the Pearson correlation and
the covariance functions necessitate complete imputation
matrices, so CMVE firstly replaces all missing values by gene
averages. Once the initial missing value estimate is generated,
then new estimated value is used in all future predictions,
which is a distinctive feature of this particular imputation
strategy.
CMVE has been proven to perform best for locally
correlated data, providing consistently superior imputation
quality compared to all the aforementioned techniques, by
virtue of the property of recycling estimated values in future
predictions [34]. It is also more robust as witnessed by its
performance in the presence of high numbers of missing
values. The main drawback of CMVE, just like all the other
contemporary algorithms, is the preset value of k which
means that it does not fully adapt to the correlation structure
of the data and compromises performance when data has a
global structure.
In summarising the imputation methods reviewed so
far, the main assumption relates to the underlying cor-
relation structure of the dataset, where KNN, LSImpute,
and CMVE perform better when data is locally correlated,
while SVDImpute and BPCA are more apposite for missing
value estimation in globally correlated datasets. From a
postgenomic knowledge inference viewpoint, however, any
estimation strategy must be adapted to the correlation data
structure so imputation performs equally well for both types
of correlated data. The next section presents two recent
flexible imputation methods that exhibit this propitious
property, in automatically adapting to the data correlation
structure to produce minimal imputation error.
5. Flexible Imputation Techniques for
Microarray Data
Flexible imputation techniques use, to some extent, core
building blocks developed for their contemporary estimation
counterparts in Section 4, and are characterised by automat-
ically selecting, a priori, the optimal number of estimator
genes from the data correlation structure. This avoids the
problem that if the data is globally correlated, then a small
number of predictor genes (low k value) may ignore genes
that are strongly correlated to the gene having the missing
value. Conversely, when an unnecessarily large value of
number of genes (high k value) is used, this can introduce
genes for prediction which either has little or no correlation
to the gene with missing values. Two techniques are reviewed
in this category.
5.1. Local Least Square Impute (LLSImpute) [8]. This is
similar to LSImpute in that it estimates missing values by
constructing a linear combination of correlated genes using
LS principles. The crucial diﬀerence is that in estimating Yi j ,
the number of predictor genes k is heuristically determined
directly from the dataset. To determine the optimum k,
LLSImpute artificially removes a known value from the most
correlated gene gi before iteratively estimating it over a range
of k values, with the k that produces the minimum estimation
error then being used for imputation.
Kim et al. [8] employed the L2 norm as well as Pearson
correlation to identify the most correlated genes, with the
L2 norm reported to perform slightly better than the Pear-
son correlation method for the chosen experimental data,
although the diﬀerence in prediction accuracies between the
two approaches was statistically insignificant.
In comparison with the various traditional and con-
temporary approaches, LLSImpute adapts to the underlying
correlated data structure, with the corollary being superior
imputation performance, and while it incurs a considerably
higher computational cost, from a microarray data perspec-
tive, missing value estimation accuracy always has a greater
priority than computational complexity.
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5.2. Heuristic Collateral Missing Value Imputation (HCMVI)
[14]. This uses the multiestimate CMVE algorithm [11]
detailed in Section 4, as its kernel building block to formulate
the final imputation of missing value Yi j . It is analogous
to LLSImpute in that it also automatically determines the
optimal number of predictor genes k by using Monte Carlo
(MC) simulation [35]. It selects multiple matrices with
known gene expression values with each matrix [36] having
a selection probability = .05 in the MC simulation. HCMVI
then identifies the most-correlated matrix from the Pearson
correlation [37] between each selected matrix and the gene
expression Y. These known values are then estimated by
CMVE for a range of k values, with the optimal k being the
one that generates the minimum estimation error.
HCMVI retains all the enhanced imputation perfor-
mance characteristics and advantages of the original CMVE
algorithm, while crucially automatically adapting to the
underlying correlation structure of the microarray data,
though as with LLSImpute, it incurs an additional compu-
tational overhead.
6. Discussion of Results
This section will rigorously examine the influence the
aforementioned imputation strategies have in improving
missing-value estimation accuracy for postgenomic knowl-
edge discovery methods such as significant gene selection
[38], allied with the biological significance of the imputation.
Six diﬀerent microarray datasets for breast and ovarian
cancer tissues are used, with data being log-transformed and
normalized, so that x = 0 and σ2 = 1, in order to remove all
experimental variations.
The breast cancer dataset [17] contained 7, 7, 8 samples
of BRCA1, BRCA2, and sporadic mutations (neither BRCA1
nor BRCA2), respectively, while the ovarian cancer dataset
[18] contained 16, 16, and 18 samples, respectively, of
BRCA1, BRCA2, sporadic mutations. Each breast cancer data
sample contained microarray data of 3226 genes and there
were 6445 genetic expressions per sample for the ovarian
dataset. It is worth noting that the number of probes in
both breast and ovarian cancer datasets is diﬀerent. The data
are generated by diﬀerent labs under diﬀerent experimental
conditions and thus represent experimental variations.
To equitably evaluate the performance of the traditional
and contemporary imputation algorithms on downstream
biological analysis methods, the number of predictor genes
was fixed at k = 10 in all experiments. In contrast, the
two flexible imputation methods (LLSImpute and HMCVI)
automatically determine k by adapting to the correlation
structure of the data. Also in this empirical analysis, the
LLSImpute variant based upon the L2 norm is applied due
to its superior performance [8]. In the next section, the
influence of imputation on both significant gene selection and
GRN reconstruction (STEP 4 in Figure 1) is investigated.
6.1. Imputation and Biological Significance of Selected Genes.
To explore the impact of each estimation algorithm upon
significant gene selection, a set of genes (Gorg) has been
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Figure 3: Gene selection accuracy for 1000 significant genes in
breast cancer.
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Figure 4: Gene selection accuracy for 50 significant genes in ovarian
cancer.
chosen from the original dataset using the between sum of
squares to within sum of squares (BSS/WSS)35 method which
identifies genes that concomitantly have large interclass and
small intraclass variations. The main reason for adopting
this particular method is its proven superior performance
capability to select significant genes compared with other
popular methods such as the t-test [39]. To assess the
eﬀect of missing values on gene selection, experiments were
performed across a missing value range of probabilities
from .01 to .2, with values being iteratively removed from
the original gene expression in (1). These were then esti-
mated using ZeroImpute, KNN, LLSImpute, BPCA, CMVE,
and HCMVI, respectively, to form Yest prior to being
applied to selected sets of p genes using BSS/WSS, for
each respective estimation matrix. The selected genes have
been then compared with Gorg to obtain the true positive
EURASIP Journal on Bioinformatics and Systems Biology 7
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Figure 5: Gene selection accuracy for 1000 significant genes in
ovarian cancer.
percentage accuracy (%Accuracy) metric, to provide a dis-
passionate measure of the estimation performance of each
algorithm.
To eliminate performance variations with respect to the
number of selected genes in the BSS/WSS method, each
imputation technique was tested for 50 and 1000 significant
genes, with the results in Figures 2, 3, 4, and 5 displaying the
respective gene selection performance for both the breast and
ovarian cancer datasets. These clearly reveal that the flexible
imputation methods (LLSImpute and HCMVI) consistently
produce superior performance for both cancer datasets,
with HCMVI provides the highest %Accuracy metric in
the experiments. In contrast, contemporary imputation
algorithms like CMVE and BPCA were unable to maintain
their performance across both datasets, though interestingly,
CMVE performed better than LLSImpute as well as all
the other contemporary imputation methods for the breast
cancer dataset, which has a predominantly localised data
correlation structure. This was not, however, maintained for
the more globally correlated ovarian cancer dataset, where
BPCA performed better, though it correspondingly failed
to sustain the improved estimation accuracy for the breast
cancer data. Not surprisingly, the high-variance traditional
imputation approaches such as ZeroImpute and KNN exhibit
the poorest performance in Figures 2–5 for both cancer
datasets, confirming the judgement that incorrectly imputed
missing values can have a significant potential impact upon
overall gene selection performance.
Imputation algorithm performance has normally only
been assessed numerically, with considerable debate within
the research community of the suitability of standard eval-
uation measures, such as normalised RMS error (NRMSE).
Interpreting the results from a biological significance per-
spective has not received the same attention, though the
impact of missing values on selected genes in postgenomic
knowledge discovery is clearly a major factor in algorithmic
performance assessment.
6.2. Biological Significance of Imputation. While the primary
focus is on the estimation accuracy of an imputation
method, it is equally important to conduct an investigation
into the biological significance of certain selected genes
for the respective datasets when evaluating the impact of
missing values on gene selection. Indeed, it is constructive to
ascertain whether a particular imputation technique assists
the gene selection methods in identifying known and novel
genes for a given sample. This may provide not only valuable
information for the design of basic mechanistic, diagnostic,
and biomarker studies, but also valuable data for use in
the construction of gene networks and pathways involved
in processes like oncogenesis and resistance to tumour
induction.
In examining the results for both the breast and ovarian
cancer datasets, a number of genes were overlooked using
traditional methods, when missing values were introduced
and processed, which independent experiments [40] have
confirmed alter expressions in tumor lines and so can be
very important in oncogenesis. This set of genes have not
only been selected by the BSS/WSS algorithm, but have
been revalidated using the modified t-test with greedy pairs
method [41] which minimizes the bias of the gene selection
strategy towards either a particular imputation technique or
a set of genes.
As the results for various gene selection algorithms in
Table 1 reveal that the KIAA1025 protein was not always
correctly selected when missing values were imputed using
KNN, BPCA CMVE, and LLSImpute, but were consistently
identified by HCMVI. This is a vital protein which is
coregulated with estrogen receptors for both in vivo and
clinical data, which are expressed in more than 66% of
human breast tumors [29]. Another gene always selected by
HCMVI across the range of missing values is plakophilin 2
(PKP2) which is a common protein and exhibits a dual role,
appearing as both a constitutive karyoplasmic protein and
a desmosomal plaque component for all the desmosome-
possessing tissues and cell culture lines. The gene is found in
breast carcinoma cell lines [25] and, furthermore, because of
its significance, it can serve as a marker for the identification
and characterisation of carcinomas derived either from or
corresponding to, simple, or complex epithelia [26].
Similar observations can be drawn from the study of
significant genes in the ovarian cancer dataset in Table 2.
For instance, MHC Class II = DQ alpha (MHCα) and
MHC Class II = DQ beta (MHCβ) genes are linked to the
immune system and have been shown to be downregulated
for ovary syndrome [27]. The allele gene is also present at
a higher frequency in patients with malignant melanoma
than in Caucasian controls. These genes help in particular to
diagnose melanoma patients in the relatively advanced stages
of the disease and/or patients who are more likely to have a
recurrence [28]. The results confirm that these genes have
been correctly identified by the flexible HCMVI method,
while being consistently overlooked by other techniques,
most notably by all traditional imputation algorithms, for
missing values probabilities greater than .05.
Interestingly, for both cancer datasets, across the full
missing value range from 1% to 20%, these regulated genes
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Table 1: KIAA1025 and plakophilin2 selection in breast cancer dataset across the range of missing values.
% MV HCMVI CMVE LLSImpute BPCA KNN ZeroImpute
1
KIAA1025 KIAA1025
KIAA1025 KIAA1025
Plakophilin2 Plakophilin2
5
KIAA1025 KIAA1025
KIAA1025 KIAA1025
Plakophilin2 Plakophilin2
10
KIAA KIAA
Plakophilin2 Plakophilin2
15
KIAA1025 KIAA1025
Plakophilin2 Plakophilin2
20
KIAA1025
Plakophilin2
Table 2: MHC class II = DQ alpha (MHCα) and MHC Class II = DQ beta (MHCβ) selection in ovarian cancer across the range of missing
values.
% MV HCMVI CMVE LLSImpute BPCA KNN ZeroImpute
1
MHCα
MHCα MHCα MHCα MHCα MHCα
MHCβ
5
MHCα
MHCβ
MHCβ
10
MHCα
MHCβ
15
MHCα
MHCβ
20
MHCα
MHCβ
have been correctly identified when gene selection has been
preceded by HCMVI imputation as confirmed in Tables
1 and 2. It highlights that consideration of the biological
significance of any imputation is extremely important and
underscores the need for accurate estimation prior to gene
selection, particularly in the presence of higher numbers of
missing values.
As alluded earlier, existing GRN reconstruction methods
conventionally replace missing values by either ZeroImpute
or gene average [30, 42], despite both inevitably impacting
upon subsequent GRN reconstruction, as will now be more
fully examined.
6.3. Impact of Missing Values on Gene Regulatory Network
Reconstruction. To evaluate the influence of missing values,
the algorithm for the reconstruction of accurate cellular net-
works (ARACNE) [43] has been employed because it aﬀords
better performance over alternative approaches like Bayesian
networks [44] and has been tested for mammalian gene
network reconstruction and compared with other techniques
that are normally applied to simple eukaryotes such as
Saccharomyces cerevisiae [45].
ARACNE firstly computes the statistical significant gene-
gene coregulation using mutual information before applying
a data processing inequality to prune indirect relationships,
that is, genes which are coregulated by either one or more
intermediate genes. To comparatively evaluate the respec-
tive imputation performances on GRN reconstruction, the
number of conserved links is determined, which represents
whether a particular coregulation link is present in both
GRNorg and GRNimputed. The gene network GRNorg is then
initially constructed using ARACNE from the original data
Y with no missing values. As in the previous experiments,
up to 20% missing values have been randomly introduced
and then, respectively, estimated using traditional, con-
temporary, and flexible imputation methods (Section 3–5,
resp.). The corresponding gene networks GRNimputed are
then constructed from the imputed data and GRNorg and
GRNimputed compared to ascertain the conserved links.
Figures 6, 7, 8, and 9 show that the ARACNE method,
which has been reported to be robust [46] for GRN
construction, does not maintain its performance in the
presence of missing values, especially for ZeroImpute. In
contrast, when a flexible imputation method like HCMVI
is applied, ARACNE conserves the number of links even at
higher missing value probabilities. For example, in BRCA1
breast cancer data, the transcriptional link between ADP-
ribosylation factor 3 (ARF3) and general transcription factor
EURASIP Journal on Bioinformatics and Systems Biology 9
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Figure 6: Accuracy of conserved links in BRCA1-breast cancer data.
20151051
Missing values (%)
HCMVI
CMVE
BPCA
LLSImpute
KNN
ZeroImpute
0
10
20
30
40
50
60
70
80
90
100
T
P
ac
cu
ra
cy
(%
)
Figure 7: Accuracy of conserved links in sporadic-breast cancer
data.
II, i, pseudogene 1(GTF2IP1) was overlooked when missing
values were imputed by all traditional and contemporary
methods, but was correctly inferred when values were
imputed by both HCMVI and LLSImpute. Similarly, the
link between HS1 binding protein and mitogen-activated
protein kinase 3 in BRCA2 breast cancer data was recon-
structed when values were imputed using HCMVI, but was
neglected by all other techniques. The results for breast
cancer sporadic data revealed similar observations, with, for
example, the interaction between ADP-ribosylation factor 3
and EST, which is very similar to the NSAP1 protein, being
identified when data was imputed using flexible methods,
while being missed by the other strategies, so corroborating
the importance of accurate imputation in improving GRN
reconstruction performance.
In the ovarian cancer dataset, the interaction link
between Ro ribonucleoprotein autoantigen (Ro/SS-A) =
20151051
Missing values (%)
HCMVI
CMVE
BPCA
LLSImpute
KNN
ZeroImpute
0
5
10
15
20
25
30
35
40
T
P
ac
cu
ra
cy
(%
)
Figure 8: Accuracy of conserved links in BRCA1-ovarian cancer
data.
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Figure 9: Accuracy of conserved links in BRCA2-ovarian cancer
data.
autoantigen calreticulin and Glutathione S-transferase theta
1 was not identified in BRCA1-data, when missing values
were introduced but was regenerated when these missing
values were imputed using HCMVI. Similarly, coregulation
between Inhibitor of DNA binding 3, dominant negative
helix-loop-helix protein, and p53 in BRCA2 ovarian cancer
dataset was also missed, but the link was reconstructed when
HMCVI imputation was applied across the range of missing
values. In the sporadic ovarian cancer dataset, transcriptional
links between CD97 and RAB-10 were again only successfully
reconstructed using HCMVI, while they were overlooked
by all other estimation methods again underpinning the
significance of accurate missing value imputation prior to
GRN reconstruction.
The impact of missing values on GRN was further
investigated on artificially created networks. Two artificial
expression datasets and networks by Bansal et al. [47] were
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Figure 10: ROC plots of artificial networks.
used for this purpose. Each expression data had 100 probes
with 100 samples per probe. The networks were constructed
using ARACNE with no imputation and compared against
artificial networks to compute reference area under receiver
operating characteristic (ROC) curve. Then, 20% missing
values were introduced and imputed using HCMVI which
was followed by network reconstruction using ARACNE
under same experimental setup to compute area under ROC
curve. Figure 10 shows average ROC curve for 10 runs with
and without imputation. The areas under ROC curve for
networks 1 and 2 were 0.6653 and 0.5979, respectively, when
networks were constructed from complete dataset. The aver-
age areas under ROC were 0.6653 and 0.5901, respectively,
when networks were constructed after randomly introducing
20% missing values and estimation using HCMVI. Again, the
result shows that network inference performance is upheld if
accurate imputation is used prior constructing networks.
6.4. Significance Test Results. For completeness, the statis-
tical significance and variance stability of all the various
imputation methods have been analysed using the two-sided
Wilcoxon rank sum statistical significance test. The impetus
for applying this test is that it does not assume that data is
coming from same distribution, which is particularly impor-
tant given the data variance can be appreciably disturbed
by erroneous estimation, as, for instance, in ZeroImpute. To
test the hypothesis H0, Y = Yest, where Y and Yest are the
actual and estimated matrices, respectively, the P-value of the
hypothesis is determined
H0, P-value = 1− 2Pr
(
R ≤ yr
)
, (3)
where yr is the sum of the ranks of observations for Y and
R is the corresponding random variable. The corresponding
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Figure 11: Significance test results for BRCA1-breast cancer data.
results shown in box plot in Figures 11, 12, 13, 14, 15, and
16 demonstrate that traditional approaches tend to rapidly
degrade at higher numbers of missing values, while both
contemporary and flexible imputation techniques maintain a
far more consistent performance across the range of missing
values, see notably in Figures 12 and 14. As box plot can
be used to display smallest observation, lower quartile,
median, upper quartile, and largest observation, and it can
also show if any value is an outlier. This corroborates the
fundamental hypothesis that a suitably accurate imputation
strategy should always be employed for microarray data
before any biological downstreaming analysis is undertaken.
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Figure 12: Significance test results for BRCA2-breast cancer data.
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Figure 13: Significance test results for sporadic-breast cancer data.
HCMVI CMVE LLSImpute BPCA KNN ZeroImpute
Imputation technique
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
P
-v
al
u
es
of
si
m
ila
ri
ty
Figure 14: Significance test results for BRCA1-ovarian cancer data.
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Figure 15: Significance test results for BRCA2-ovarian cancer data.
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Figure 16: Significance test results for sporadic-ovarian cancer
data.
6.5. Normalized Root Mean Square Error. For completeness,
the estimation performance of HCMVI and comparative
imputation methods was also analysed using the traditional
parametric normalised root mean square (NRMS) error
measure, despite its limitations in reflecting the true impact
of missing values on subsequent biological analysis. NRMS
Error is defined as
Θ = RMS
(
Y − Yest
)
RMS(Y)
, (4)
where Y is the original data matrix and Yest is the estimated
matrix using HCMVI, CMVE, BPCA, LLSImpute, and KNN,
respectively. This particular measure has been used by Sehgal
et al. [11], Ouyang et al. [48], and Tuikkala et al. [6] for error
estimation because Θ = 1 for zero imputation.
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Figure 17: NRMS error in BRCA1-breast cancer data.
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Figure 18: NRMS error in BRCA2-breast cancer data.
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Figure 19: NRMS error in sporadic-breast cancer data.
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Figure 20: NRMS error in BRCA1-ovarian cancer data.
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Figure 21: NRMS error in BRCA2-ovarian cancer data.
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Figure 22: NRMS error in sporadic-ovarian cancer data.
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Figures 17, 18, 19, 20, 21, and 22 show box plot of NMRS
error for diﬀerent imputation algorithms (see Supplemen-
tary Material available online at doi: 10.1155/2009/717136
for the rest of the results). It again confirms the better per-
formance of HCMVI (see notably Figure 19) and reiterates
the value of accurately exploiting information about the
underlying correlation structure of the data instead of using
a preset value. Interestingly, LLSImpute exhibited similar
performance to HCMVI so justifying the merit of using
other metrics to dispassionately compare the performance of
diﬀerent imputation strategies.
7. Conclusion
This paper has pragmatically argued that imputation can be
eﬀectively applied to recycle microarray data and in doing
so provide many potential benefits ranging from cost savings
to performance enhancements in postgenomic knowledge
discovery. While cognisance is made that ZeroImpute and
other traditional missing value imputation strategies are
straightforward to implement, new flexible methods have
been proven to exhibit much superior accuracy and per-
formance from both a statistical and biological significance
perspectives, by virtue of their innate ability to exploit
any underlying data correlation structures. A comprehen-
sive study of missing values in microarray data has been
presented and their subsequent impact upon postgenomic
knowledge discovery methods, including significant gene
selection and gene regulatory network reconstruction, has
been investigated. Empirical analysis has consistently shown
that rather than merely ignoring missing values, which has
been the preferred approach to resolve this problem, flex-
ible and robust imputation algorithms aﬀord considerable
performance benefits and so should, wherever possible, be
mandated prior to any knowledge inference process using
microarray data.
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